A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice

Am J Transplant. 2019 Dec;19(12):3377-3389. doi: 10.1111/ajt.15550. Epub 2019 Aug 26.

Abstract

Chronic lung allograft dysfunction (CLAD) limits long-term survival after lung transplant (LT). Ischemia-reperfusion injury (IRI) promotes chronic rejection (CR) and CLAD, but the underlying mechanisms are not well understood. To examine mechanisms linking IRI to CR, a mouse orthotopic LT model using a minor alloantigen strain mismatch (C57BL/10 [B10, H-2b ] → C57BL/6 [B6, H-2b ]) and isograft controls (B6→B6) was used with antecedent minimal or prolonged graft storage. The latter resulted in IRI with subsequent airway and parenchymal fibrosis in prolonged storage allografts but not isografts. This pattern of CR after IRI was associated with the formation of B cell-rich tertiary lymphoid organs within the grafts and circulating autoantibodies. These processes were attenuated by B cell depletion, despite preservation of allograft T cell content. Our observations suggest that IRI may promote B cell recruitment that drives CR after LT. These observations have implications for the mechanisms leading to CLAD after LT.

Keywords: B cell biology; animal models: murine; basic (laboratory) research/science; bronchiolitis obliterans (BOS); immunobiology; immunosuppression/immune modulation; innate immunity; lung (allograft) function/dysfunction; lung transplantation/pulmonology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Animals
  • Autoantibodies / immunology*
  • B-Lymphocytes / immunology*
  • Chronic Disease
  • Disease Models, Animal
  • Fibrosis / etiology
  • Fibrosis / pathology*
  • Graft Rejection / etiology
  • Graft Rejection / pathology*
  • Graft Survival / immunology*
  • Lung Transplantation / adverse effects*
  • Male
  • Mice
  • Reperfusion Injury / complications*
  • Reperfusion Injury / pathology

Substances

  • Autoantibodies